期刊文献+

LC-MS/MS测定艾司奥美拉唑钠中潜在基因毒性杂质2-氯甲基-3,5-二甲基-4-甲氧基吡啶 被引量:3

Determination of Potential Genotoxic Impurity 2-Chloromethyl-4-methoxy-3,5-dimethylpyridine in Esomeprazole Sodium by LC-MS/MS
下载PDF
导出
摘要 目的:建立LC-MS/MS法测定艾司奥美拉唑钠中潜在基因毒性杂质2-氯甲基-3,5-二甲基-4-甲氧基吡啶。方法:色谱柱为Poroshell 120 EC-C18柱(50 mm×4.6 mm,2.7μm),柱温:30℃,流动相为水-乙腈(60∶40)(含0.2%甲酸),流速:0.5 ml·min^(-1)。采用电喷雾离子源(ESI),以多反应监测模式(MRM)进行正离子扫描,定量离子对为质荷比(m/z) 186→150.2,定性离子对为质荷比(m/z) 186→120.1。结果:在该色谱条件下,2-氯甲基-3,5-二甲基-4-甲氧基吡啶在0.825 8~165.166 7 ng·ml^(-1)浓度范围内线性关系良好(r=0.999 9),平均回收率为90.2%(RSD=1.6%,n=9),检测限为0.330 3 ng·ml^(-1),方法检测限为0.033μg·g^(-1)。结论:该分析方法简便高效,能有效准确的测定艾司奥美拉唑钠中的潜在基因毒性杂质2-氯甲基-3,5-二甲基-4-甲氧基吡啶。 Objective: To establish an HPLC-MS/MS analytical method for the determination of potential genotoxic impurity 2-chloromethyl-4-methoxy-3,5-dimethylpyridine in esomeprazole sodium. Methods: The separation was carried out on a Poroshell 120 EC-C18(50 mm×4.6 mm,2.7 μm) column at the column temperature at 30℃ and flow rate of 0.5 ml·min^(-1). The mobile phase was a mixture of 0.2% formic acid and 40% acetonitrile in water. Mass spectrometry was operated in electrospray ionization(ESI) with multiple reactions monitoring mode(MRM). The quantitative and qualitative ion pairs were m/z 186→150.2 and m/z 186→120.1. Results: The method had good specificity and promising linearity ranged from 0.825 8 ng·ml^(-1) to 165.166 7 ng·ml^(-1)(r = 0.999 9).The average recovery was 90.2%(RSD = 1.6%,n = 9). The detection limit and method detection limit was 0.330 3 ng·ml^(-1) and 0.033μg·g^(-1),respectively. Conclusion: The method is simple,accurate and reliable,which can be applied to determine 2-chloromethyl-4-methoxy-3,5-dimethylpyridine in esomeprazole sodium.
作者 王璐 刘峰 Wang Lu;Liu Feng(Sichuan Institute for Food and Drug Control,Chengdu 611731,China)
出处 《中国药师》 CAS 2021年第2期399-401,共3页 China Pharmacist
关键词 艾司奥美拉唑钠 2-氯甲基-3 5-二甲基-4-甲氧基吡啶 潜在基因毒性杂质 液质联用 Esomeprazole sodium 2-Chloromethyl-4-methoxy-3 5-dimethylpyridine Potential genotoxic impurity LC-MS/MS
  • 相关文献

参考文献4

二级参考文献35

  • 1楼雅卿,赵莉,张远.中国健康志愿者的奥美拉唑及其代谢物的药代动力学研究[J].中国临床药理学杂志,1994,10(1):14-21. 被引量:27
  • 2傅建渭,陶兴法,傅诏娟,王井明.奥美拉唑的合成[J].中国医药工业杂志,2007,38(2):78-80. 被引量:14
  • 3Mittelbach M, Schmidt HW, Uray G, et al.Synthesis of 4-methoxy-2,3,5-trimethylpyridine: a specific building block for compounds with gastric-acid inhibiting activity [J].Acta Chem, Scand B, 1988, 42 (8): 524-529.
  • 4Lang HJ, Weidmann K, Scheunemann KH, et al.Preparation of thienoimidazole derivatives as gastric secretion inhibitors[P].DE: 3837411, 1989-06-01.(CA 1990, 112: 55859y)
  • 5Dodd DS, Nishi T.Preparation of 1,3,4-oxadiazole useful as immunosuppressants, antiinflammatories, and hepatoprotectants [P].US: 5670526, 1997-07-23.(CA 1997, 127:307388n)
  • 6Braendstroem AE, Lamm BR.3,5-Dimethyl-4-methoxypyridine 1-oxide[P].EP: 103553, 1984-03-21.(CA 1984, 101:72613d)
  • 7Scott LJ,Dunn ChJ,Mallarkey G,et al.Esomeprazole:a review of its use in the management of acid-related disorders in the US[J].Drugs,2002,62(7):1091-1118.
  • 8Scott LJ,Dunn ChJ,Mallarkey G,et al.Esomeprazole:a review of its use in the management of acid-related disorders in the US[J].Drugs,2002,62(10):1503-1538.
  • 9Andersson T,Bredberg E,Sunzel M,et al.Pharmacokinetics and effect on pentagastrin stimulated peak acid output (PAO) of omeprazole and its 2 optical isomers,S-omeprazole / esomeprazole and R-omeprazole[J].Gastroenterology,2000,118∶A1210.
  • 10Abelo A,Andersson TB,Antonsson M,et al.Stereoselective metabolism of omeprazole by human cytochrome P450 enzymes[J].Drug Metab Dispos,2000,28(8):966-972.

共引文献67

同被引文献33

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部